1 August 17, 2018 Subject: Capital Increase for Offering for Sale to Specific Investors (Private Placement), Connected Transaction, Amendments to Articles of Association/Objectives of the Company and Determination of the Date of Extraordinary General Meeting of Shareholders No. 1/2018 To: President The Stock Exchange of Thailand Enclosures: 1. Information Memorandum on the Offering of Newly Issued Ordinary Shares to Specific Investors (Private Placement) at the Offering Price with a Discount of...

Central Pattana Public Company Limited (“The Company” or “CPN”) in 2Q19 shows total revenue of THB 9,197 mn, an increase of 0.7% and net profit stood at THB 2,470 mn, a decrease of 15.9% from the same

financial methods used to consider the appropriateness of the price to enter into the transaction. The Independent Financial Advisor used 2 financial methods as follows: 1) Book Value Approach 2) Adjusted

E_1 Legal_FA_2015_12_29-c A CorpL4.1hig A Executive Summary of Management Discussion and Analysis 1 For the Year Ending December 31, 2019 Thai economy in 2019 showed decelerating growth at 2.4 percent compared to 4.2 percent in the previous year.The slowdown could be attributed to exports which contracted further due to the stronger Baht and a global economic slowdown. In addition, the investment environment of both the public and private sector remained weak, and private consumption, albeit gro...

also due to a decrease in interest rates. Nevertheless, loan demand for investment declined, both for fixed investment and inventory buildup purposes. Demand for consumer loans declined in all categories

Business unit was decrease by THB 291 million or 12% mainly due to the soften of methyl ester price following in CPO price falling and the soften of by-product revenue from glycerin price declining, though

. • Electricity price sales to IU in Vietnam decreased 4.8% y-on-y and increased 1.3% q-on-q (2.36 Baht/KWh in 9M’2018 / 2.39 Baht/KWh in Q3’2018), primarily due to a decrease or increase in the prevailing retail

business operators and the general public interested in the acquisition of the assets to offer a bidding price for each asset in accordance with the methods and conditions specified by the Company. The

Compensation is referencing on the negotiation between buyer and seller. The Company has set criteria to determine the Value of Compensation in various methods based on the financial status of Modern Pharma

subsidiaries performance in Q1/2018 recorded a Net Profit of THB 1,337 million, compared to Q1/2017 a decrease of THB 861 million (-39% YoY), and when compared to Q4/2017 decreased by THB 230 million (-15% QoQ